MyFinsight
Home
Blog
About
Back
Income Statement
Silence Therapeutics plc (SLNCF)
Silence Therapeutics plc (SLNCF)
source: myfinsight.com
Net loss
-$12,268K
Loss before income
tax expense
-$12,267K
Income tax expense
$1K
Benefit from r&d credit
$778K
Other income, net
$669K
Foreign currency
gain/(loss), net
$151K
Operating loss
-$13,865K
Research and development
costs
$9,148K
General and
administrative expenses
$4,717K
Back